Pharvaris is a late-stage biopharmaceutical company developing novel oral bradykinin B2 receptor antagonists to address various forms of bradykinin-mediated angioedema. By targeting this clinically proven therapeutic target with innovative oral small molecules, the Pharvaris team is creating new alternatives to injected therapies for preventing and treating hereditary angioedema (HAE) attacks, as well as other indications related to bradykinin B2 receptor mediation. HAE is a rare and potentially life-threatening genetic disorder in which patients may experience sudden and prolonged swelling attacks in various parts of the body, including the airway, which can be dangerous. We are expanding our U.S. Commercial team and seek to establish our Thought Leader Liaison Team in the U.S. This role reports into the Head of Thought Leader Development, North America, contributing to team-wide objectives while executing locally with a high degree of autonomy and accountability. The Thought Leader Liaison (TLL) is a field-based commercial role responsible for building, managing, and deepening relationships with key thought leaders across academic and community settings within a defined geography. The TLL serves as a primary connector between external influencers and internal stakeholders, ensuring high-quality insight generation that informs commercial strategy and execution.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior